Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 16:13:912820.
doi: 10.3389/fneur.2022.912820. eCollection 2022.

Cognitive and Autonomic Dysfunction in Multiple System Atrophy Type P and C: A Comparative Study

Affiliations

Cognitive and Autonomic Dysfunction in Multiple System Atrophy Type P and C: A Comparative Study

Giulia Lazzeri et al. Front Neurol. .

Abstract

Multiple System Atrophy (MSA) is a rare neurodegenerative disease, clinically defined by a combination of autonomic dysfunction and motor involvement, that may be predominantly extrapyramidal (MSA-P) or cerebellar (MSA-C). Although dementia is generally considered a red flag against the clinical diagnosis of MSA, in the last decade the evidence of cognitive impairment in MSA patients has been growing. Cognitive dysfunction appears to involve mainly, but not exclusively, executive functions, and may have different characteristics and progression in the two subtypes of the disease (i.e., MSA-P and MSA-C). Despite continued efforts, combining in-vivo imaging studies as well as pathological studies, the physiopathological bases of cognitive involvement in MSA are still unclear. In this view, the possible link between cardiovascular autonomic impairment and decreased cognitive performance, extensively investigated in PD, needs to be clarified as well. In the present study, we evaluated a cohort of 20 MSA patients (9 MSA-P, 11 MSA-C) by means of a neuropsychological battery, hemodynamic assessment (heart rate and arterial blood pressure) during rest and active standing and bedside autonomic function tests assessed by heart rate variability (HRV) parameters and sympathetic skin response (SSR) in the same experimental session. Overall, global cognitive functioning, as indicated by the MoCA score, was preserved in most patients. However, short- and long-term memory and attentional and frontal-executive functions were moderately impaired. When comparing MSA-P and MSA-C, the latter obtained lower scores in tests of executive functions and verbal memory. Conversely, no statistically significant difference in cardiovascular autonomic parameters was identified between MSA-P and MSA-C patients. In conclusion, moderate cognitive deficits, involving executive functions and memory, are present in MSA, particularly in MSA-C patients. In addition, our findings do not support the role of dysautonomia as a major driver of cognitive differences between MSA-P and MSA-C.

Keywords: cognitive dysfunction; dysautonomia; heart rate variability; multiple system atrophy; neuropsychological assessment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Fanciulli A, Wenning GK. Multiple-system atrophy. N Engl J Med. (2015) 372:249–63. 10.1056/NEJMra1311488 - DOI - PubMed
    1. Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, et al. . Second consensus statement on the diagnosis of multiple system atrophy. Neurology. (2008) 71:670–6. 10.1212/01.wnl.0000324625.00404.15 - DOI - PMC - PubMed
    1. Wenning GK, Ben-Shlomo Y, Hughes A, Daniel SE, Lees A, Quinn NP. What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? J Neurol Neurosurg Psychiatry. (2000) 68:434–40. 10.1136/jnnp.68.4.434 - DOI - PMC - PubMed
    1. O'Sullivan SS, Massey LA, Williams DR, Silveira-Moriyama L, Kempster PA, Holton JL, et al. . Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain. (2008) 131(Pt. 5):1362–72. 10.1093/brain/awn065 - DOI - PubMed
    1. Brown RG, Lacomblez L, Landwehrmeyer BG, Bak T, Uttner I, Dubois B, et al. . Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain. (2010) 133:2382–93. 10.1093/brain/awq158 - DOI - PubMed